You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.

Clinical Advances in

Progressive Fibrosing Interstitial Lung Diseases

Progressive fibrosing interstitial lung diseases (ILDs)—including idiopathic pulmonary fibrosis (IPF), systemic sclerosis-associated interstitial lung disease (SSc-ILD), and others—can be challenging to identify, treat, and effectively monitor in practice. However, diagnostic and treatment approaches are fast evolving, and best practice is changing. Experts in this curriculum will address how the latest data can be applied to practice to reduce the rates of morbidity and mortality for these highly burdensome conditions.

Supported by an independent educational grant from

Boehringer Ingelheim

CME Activities


Polling Question


Steering Committee

Vincent Cottin, MD, PhD
Vincent Cottin, MD, PhD

Steering Committee Chair

University of Lyon
Hôpital Louis Pradel
Lyon, France

Oliver Distler, MD
Oliver Distler, MD

Department of Rheumatology
Hospital Zurich
Zurich, Switzerland

Anna Hoffman-Vold, MD, PhD
Anna Hoffmann-Vold, MD, PhD

University Hospital of Oslo
Oslo, Norway

Simon Walsh, MD, PhD
Simon Walsh, MD, PhD

Thoracic Radiologist
NIHR Clinician Scientist
Imperial College London
London, United Kingdom

Martin Kolb, MD, PhD
Martin Kolb, MD, PhD

Division of Respirology
Department of Medicine
McMaster University
Hamilton, Ontario, Canada

Antje Prasse, MD
Antje Prasse, MD

Department of Pulmonology
Hannover Medical School
Hannover, Germany